NeuroPace(NPCE)
MOUNTAIN VIEW, CAMedical Devices
Focus: NeuroPace is a publicly traded medical device company specializing in implantable responsive neurostimulation systems, primarily for epilepsy treatment. The company is a focused player in neuromodulation with ~$80M in annual revenue and a $55B+ addressable market opportunity.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
13+6 this month
Growing — net +6 jobs in 30d
6 jobs added vs 0 removed. Steady team buildout.
Should You Work at NeuroPace?
AI assessmentNeuroPace offers strong commercial growth and market opportunity for sales/marketing professionals, but narrow cash reserves, recent regulatory disappointment, and device-only portfolio limit appeal for R&D and research-focused careers.
Why Work Here
- Strong revenue momentum: 23% YoY growth (FY2025: $80M vs FY2024: $65M) with Q2 2026 earnings beat and raised guidance signals market traction
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$80M
Pipeline & Clinical Trials
electrical stimulation
EpilepsyClinical Trials (1)
NCT02781129Navigation and Free Recall in Chronically Implanted Humans
N/AHelp build intelligence for NeuroPace
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.